COVID-19 and the liver: What do we know so far?

doi:10.4254/wjh.v13.i5.522

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8328)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

616

WORD

213

HTML

4083

Figures (1-2)

295

Tables (1-1)

331

Sum=5538

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

387

Download

970

Sum=1357

Publishing Process of This Article

Item

Count

Browse

419

Download

1014

Sum=1433

May 27, 2021 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Opinion Review

World J Hepatol. May 27, 2021; 13(5): 522-532
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.522

Full Size Figure Download Figure

Figure 2 General measures for the safe management of patients with pre-existing liver disease during coronavirus disease 2019 pandemic. COVID-19: Coronavirus disease 2019.

Citation: Nasa P, Alexander G. COVID-19 and the liver: What do we know so far? World J Hepatol 2021; 13(5): 522-532
URL: https://www.wjgnet.com/1948-5182/full/v13/i5/522.htm
DOI: https://dx.doi.org/10.4254/wjh.v13.i5.522